{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:02:26Z","timestamp":1756076546892,"version":"3.37.3"},"reference-count":47,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81803430"],"award-info":[{"award-number":["81803430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BE2019650"],"award-info":[{"award-number":["BE2019650"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013145","name":"R&D Program of Zhejiang","doi-asserted-by":"publisher","award":["2022C03145"],"award-info":[{"award-number":["2022C03145"]}],"id":[{"id":"10.13039\/501100013145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018532","name":"Major scientific and technological innovation projects of Shandong Province","doi-asserted-by":"publisher","award":["2019JZZY020907"],"award-info":[{"award-number":["2019JZZY020907"]}],"id":[{"id":"10.13039\/501100018532","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and technology projects of traditional Chinese medicine of Shandong Province","award":["2020Z52"],"award-info":[{"award-number":["2020Z52"]}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Phosphodiesterase type 5 (PDE5), exclusively specific for cyclic guanidine\nmonophosphate (cGMP), a potential target for the therapy of various diseases, and PDE5 inhibitors\ncould be used as a treatment for erectile dysfunction (ED) or chronic pulmonary hypertension.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>In the present study, we carried out an integrated computer-aided virtual screening\ntechnique against the natural products in the ZINC database to discover potential inhibitors of\nPDE5.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Pharmacophore, molecular docking and ADMET (Absorption, distribution, metabolism,\nexcretion and toxicity) properties filtration were used to select the PDE5 inhibitors with the best\nbinding affinities and drug-like properties. The binding modes of PDE5 inhibitors were investigated,\nand these complexes' stabilities were explored by molecular dynamic simulations and\nMM\/GBSA free energy calculations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Two natural compounds (Z171 and Z283) were identified and may be used as a critical\nstarting point for the development of novel PDE5 inhibitors. The MM\/GBSA free energy decomposition\nanalysis quantitatively analyzed the importance of hydrophobic interaction in PDE5-\nligands binding.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In this study, we identified two novel natural compounds from the ZINC database to\neffectively inhibit PDE5 through virtual screening. The novel scaffolds of these compounds can be\nused as the starting templates in the drug design of PDE5 inhibitors with good pharmacokinetic\nprofiles. These results may promote the de novo design of new compounds against PDE5.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409919666221208143327","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T05:34:21Z","timestamp":1670823261000},"page":"234-242","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of Potential Inhibitors of PDE5 based on Structure-based\nVirtual Screening Approaches"],"prefix":"10.2174","volume":"19","author":[{"given":"Lei","family":"Xu","sequence":"first","affiliation":[{"name":"Institute of Bioinformatics and Medical Engineering, Jiangsu University of Technology, Changzhou 213001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilei","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiology, Weifang Second People's Hospital, Weifang 261041, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Orthopedics,\nThe Second Affiliated Hospital of Soochow University, Suzhou 215004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Thyroid and Breast Surgery,\nWeifang People's Hospital, Weifang 261000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingcong","family":"Yu","sequence":"additional","affiliation":[{"name":"Clinical Institute Affiliated to Wenzhou Medical University,\nWenzhou People's Hospital, Wenzhou 2325099, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibin","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong Technology Innovation Center of Gelatin-based Traditional\nChinese Medicine, Dong-E-E-Jiao Co. Ltd., Liaocheng, 252201, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianfeng","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Engineering\nand Life Sciences, Changzhou University, Changzhou 213164, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.1021\/jp066582+","volume":"111","author":"Salter E.A.","year":"2007","unstructured":"Salter E.A.; Wierzbicki A.; The mechanism of cyclic nucleotide hydrolysis in the phosphodiesterase catalytic site. J Phys Chem B 2007,111(17),4547-4552","journal-title":"J Phys Chem B"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nrd4228","volume":"13","author":"Maurice D.H.","year":"2014","unstructured":"Maurice D.H.; Ke H.; Ahmad F.; Wang Y.; Chung J.; Manganiello V.C.; Advances in targeting cyclic nucleotide phosphodiesterases. Nat Rev Drug Discov 2014,13(4),290-314","journal-title":"Nat Rev Drug Discov"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev.biochem.76.060305.150444","volume":"76","author":"Conti M.","year":"2007","unstructured":"Conti M.; Beavo J.; Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling. Annu Rev Biochem 2007,76(1),481-511","journal-title":"Annu Rev Biochem"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","volume":"100","author":"Omori K.","year":"2007","unstructured":"Omori K.; Kotera J.; Overview of PDEs and their regulation. Circ Res 2007,100(3),309-327","journal-title":"Circ Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrd893","volume":"1","author":"Rotella D.P.","year":"2002","unstructured":"Rotella D.P.; Phosphodiesterase 5 inhibitors: Current status and potential applications. Nat Rev Drug Discov 2002,1(9),674-682","journal-title":"Nat Rev Drug Discov"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","volume":"274","author":"Corbin J.D.","year":"1999","unstructured":"Corbin J.D.; Francis S.H.; Cyclic GMP phosphodiesterase-5: Target of sildenafil. J Biol Chem 1999,274(20),13729-13732","journal-title":"J Biol Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/j.1745-7254.2007.00611.x","volume":"28","author":"Yoo H.","year":"2007","unstructured":"Yoo H.; Kim N.; Im G.; Kim D.; Pharmacokinetics and tissue distribution of a novel PDE5 inhibitor, SK-3530, in rats. Acta Pharmacol Sin 2007,28(8),1247-1253","journal-title":"Acta Pharmacol Sin"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/sj.ijir.3901283","volume":"17","author":"Weeks J.L.","year":"2005","unstructured":"Weeks J.L.; Zoraghi R.; Beasley A.; Sekhar K.R.; Francis S.H.; Corbin J.D.; High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients. Int J Impot Res 2005,17(1),5-9","journal-title":"Int J Impot Res"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1517\/14656566.2013.799665","volume":"14","author":"Bruzziches R.","year":"2013","unstructured":"Bruzziches R.; Francomano D.; Gareri P.; Lenzi A.; Aversa A.; An update on pharmacological treatment of erectile dysfunction with phosphodiesterase type 5 inhibitors. Expert Opin Pharmacother 2013,14(10),1333-1344","journal-title":"Expert Opin Pharmacother"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1021\/cn3000907","volume":"3","author":"Garc\u00eda-Osta A.","year":"2012","unstructured":"Garc\u00eda-Osta A.; Cuadrado-Tejedor M.; Garc\u00eda-Barroso C.; Oyarz\u00e1bal J.; Franco R.; Phosphodiesterases as therapeutic targets for Alz-heimer\u2019s disease. ACS Chem Neurosci 2012,3(11),832-844","journal-title":"ACS Chem Neurosci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/nan.12203","volume":"41","author":"Ugarte A.","year":"2015","unstructured":"Ugarte A.; Gil-Bea F.; Garc\u00eda-Barroso C.; Cedazo-Minguez \u00c1.; Ram\u00edrez M.J.; Franco R.; Garc\u00eda-Osta A.; Oyarzabal J.; Cuadrado-Tejedor M.; Decreased levels of guanosine 3\u2032, 5\u2032-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive de-cline and amyloid pathology in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 2015,41(4),471-482","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/j.1476-5381.2011.01517.x","volume":"164","author":"Cuadrado-Tejedor M.","year":"2011","unstructured":"Cuadrado-Tejedor M.; Hervias I.; Ricobaraza A.; Puerta E.; P\u00e9rez-Rold\u00e1n J.M.; Garc\u00eda-Barroso C.; Franco R.; Aguirre N.; Garc\u00eda-Osta A.; Sildenafil restores cognitive function without affecting \u03b2-amyloid burden in a mouse model of Alzheimer\u2019s disease. Br J Pharmacol 2011,164(8),2029-2041","journal-title":"Br J Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuropharm.2012.06.052","volume":"64","author":"Garc\u00eda-Barroso C.","year":"2013","unstructured":"Garc\u00eda-Barroso C.; Ricobaraza A.; Pascual-Lucas M.; Unceta N.; Rico A.J.; Goicolea M.A.; Sall\u00e9s J.; Lanciego J.L.; Oyarzabal J.; Franco R.; Cuadrado-Tejedor M.; Garc\u00eda-Osta A.; Tadalafil crosses the blood\u2013brain barrier and reverses cognitive dysfunction in a mouse model of AD. Neuropharmacology 2013,64,114-123","journal-title":"Neuropharmacology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/med.20053","volume":"26","author":"Pissarnitski D.","year":"2006","unstructured":"Pissarnitski D.; Phosphodiesterase 5 (PDE 5) inhibitors for the treatment of male erectile disorder: Attaining selectivity versus PDE6. Med Res Rev 2006,26(3),369-395","journal-title":"Med Res Rev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.eururo.2006.01.028","volume":"49","author":"Wespes E.","year":"2006","unstructured":"Wespes E.; Amar E.; Hatzichristou D.; Hatzimouratidis K.; Montorsi F.; Pryor J.; Vardi Y.; EAU Guidelines on erectile dysfunction: an update. Eur Urol 2006,49(5),806-815","journal-title":"Eur Urol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s11934-011-0216-y","volume":"12","author":"Chung E.","year":"2011","unstructured":"Chung E.; Brock G.B.; Emerging and novel therapeutic approaches in the treatment of male erectile dysfunction. Curr Urol Rep 2011,12(6),432-443","journal-title":"Curr Urol Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0031-9422(02)00621-0","volume":"62","author":"Drewes S.E.","year":"2003","unstructured":"Drewes S.E.; George J.; Khan F.; Recent findings on natural products with erectile-dysfunction activity. Phytochemistry 2003,62(7),1019-1025","journal-title":"Phytochemistry"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1126\/science.1168243","volume":"325","author":"Li J.W.H.","year":"2009","unstructured":"Li J.W.H.; Vederas J.C.; Drug discovery and natural products: end of an era or an endless frontier? Science 2009,325(5937),161-165","journal-title":"Science"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bioorg.2013.07.001","volume":"50","author":"Rodr\u00edguez-Ramos F.","year":"2013","unstructured":"Rodr\u00edguez-Ramos F.; Navarrete A.; Gonz\u00e1lez-Andrade M.; Alarc\u00f3n C.; Aguilera-Cruz A.; Reyes-Ram\u00edrez A.; Synthesis, docking study and relaxant effect of 2-alkyl and 2-naphthylchromones on rat aorta and guinea-pig trachea through phosphodiesterase inhibition. Bioorg Chem 2013,50,17-25","journal-title":"Bioorg Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.phytochem.2005.11.019","volume":"67","author":"Ojewole J.A.O.","year":"2006","unstructured":"Ojewole J.A.O.; Drewes S.E.; Khan F.; Vasodilatory and hypoglycaemic effects of two pyrano-isoflavone extractives from Eriosema kraussianum N. E. Br. [Fabaceae] rootstock in experimental rat models. Phytochemistry 2006,67(6),610-617","journal-title":"Phytochemistry"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.fitote.2015.06.020","volume":"105","author":"Ribaudo G.","year":"2015","unstructured":"Ribaudo G.; Pagano M.A.; Pavan V.; Redaelli M.; Zorzan M.; Pezzani R.; Mucignat-Caretta C.; Vendrame T.; Bova S.; Zagotto G.; Semi-synthetic derivatives of natural isoflavones from Maclura pomifera as a novel class of PDE-5A inhibitors. Fitoterapia 2015,105,132-138","journal-title":"Fitoterapia"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"Irwin J.J.","year":"2012","unstructured":"Irwin J.J.; Sterling T.; Mysinger M.M.; Bolstad E.S.; Coleman R.G.; ZINC: A free tool to discover chemistry for biology. J Chem Inf Model 2012,52(7),1757-1768","journal-title":"J Chem Inf Model"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","volume":"12","author":"Card G.L.","year":"2004","unstructured":"Card G.L.; England B.P.; Suzuki Y.; Fong D.; Powell B.; Lee B.; Luu C.; Tabrizizad M.; Gillette S.; Ibrahim P.N.; Artis D.R.; Bollag G.; Milburn M.V.; Kim S.H.; Schlessinger J.; Zhang K.Y.J.; Structural basis for the activity of drugs that inhibit phosphodiesterases. Structure 2004,12(12),2233-2247","journal-title":"Structure"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","volume":"30","author":"Brooks B.R.","year":"2009","unstructured":"Brooks B.R.; Brooks C.L.; Mackerell A.D.; Nilsson L.; Petrella R.J.; Roux B.; Won Y.; Archontis G.; Bartels C.; Boresch S.; Caflisch A.; Caves L.; Cui Q.; Dinner A.R.; Feig M.; Fischer S.; Gao J.; Hodoscek M.; Im W.; Kuczera K.; Lazaridis T.; Ma J.; Ovchinnikov V.; Paci E.; Pastor R.W.; Post C.B.; Pu J.Z.; Schaefer M.; Tidor B.; Venable R.M.; Woodcock H.L.; Wu X.; Yang W.; York D.M.; Karplus M.; CHARMM: The biomolecular simulation program. J Comput Chem 2009,30(10),1545-1614","journal-title":"J Comput Chem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1021\/ci300250q","volume":"52","author":"Feng Z.","year":"2012","unstructured":"Feng Z.; Hou T.; Li Y.; Concerted movement in pH-dependent gating of FocA from molecular dynamics simulations. J Chem Inf Model 2012,52(8),2119-2131","journal-title":"J Chem Inf Model"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1021\/ci200594d","volume":"52","author":"Feng Z.","year":"2012","unstructured":"Feng Z.; Hou T.; Li Y.; Studies on the interactions between \u03b22 adrenergic receptor and Gs protein by molecular dynamics simulations. J Chem Inf Model 2012,52(4),1005-1014","journal-title":"J Chem Inf Model"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1021\/ci5002718","volume":"54","author":"Feng Z.","year":"2014","unstructured":"Feng Z.; Alqarni M.H.; Yang P.; Tong Q.; Chowdhury A.; Wang L.; Xie X.Q.; Modeling, molecular dynamics simulation, and mutation validation for structure of cannabinoid receptor 2 based on known crystal structures of GPCRs. J Chem Inf Model 2014,54(9),2483-2499","journal-title":"J Chem Inf Model"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1002\/jcc.20035","volume":"25","author":"Wang J.","year":"2004","unstructured":"Wang J.; Wolf R.M.; Caldwell J.W.; Kollman P.A.; Case D.A.; Development and testing of a general amber force field. J Comput Chem 2004,25(9),1157-1174","journal-title":"J Comput Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"Maier J.A.","year":"2015","unstructured":"Maier J.A.; Martinez C.; Kasavajhala K.; Wickstrom L.; Hauser K.E.; Simmerling C.; ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 2015,11(8),3696-3713","journal-title":"J Chem Theory Comput"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/ct1002626","volume":"6","author":"Peters M.B.","year":"2010","unstructured":"Peters M.B.; Yang Y.; Wang B.; F\u00fcsti-Moln\u00e1r L.; Weaver M.N.; Merz K.M.; Jr Structural survey of zinc containing proteins and the development of the zinc AMBER force field (ZAFF). J Chem Theory Comput 2010,6(9),2935-2947","journal-title":"J Chem Theory Comput"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1021\/ci400188q","volume":"53","author":"Sun H.","year":"2013","unstructured":"Sun H.; Li Y.; Li D.; Hou T.; Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches. J Chem Inf Model 2013,53(9),2376-2389","journal-title":"J Chem Inf Model"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1021\/ci300375k","volume":"52","author":"Li L.","year":"2012","unstructured":"Li L.; Li Y.; Zhang L.; Hou T.; Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A\/H1N1 influenza neu-raminidase. J Chem Inf Model 2012,52(10),2715-2729","journal-title":"J Chem Inf Model"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1021\/jm401908w","volume":"57","author":"Xu L.","year":"2014","unstructured":"Xu L.; Zhang Y.; Zheng L.; Qiao C.; Li Y.; Li D.; Zhen X.; Hou T.; Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays. J Med Chem 2014,57(9),3737-3745","journal-title":"J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.antiviral.2013.09.006","volume":"100","author":"Pan P.","year":"2013","unstructured":"Pan P.; Li L.; Li Y.; Li D.; Hou T.; Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations. Antiviral Res 2013,100(2),356-364","journal-title":"Antiviral Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"16719","DOI":"10.1039\/C4CP01388C","volume":"16","author":"Sun H.","year":"2014","unstructured":"Sun H.; Li Y.; Tian S.; Xu L.; Hou T.; Assessing the performance of MM\/PBSA and MM\/GBSA methods. 4. Accuracies of MM\/PBSA and MM\/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. Phys Chem Chem Phys 2014,16(31),16719-16729","journal-title":"Phys Chem Chem Phys"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"22035","DOI":"10.1039\/C4CP03179B","volume":"16","author":"Sun H.","year":"2014","unstructured":"Sun H.; Li Y.; Shen M.; Tian S.; Xu L.; Pan P.; Guan Y.; Hou T.; Assessing the performance of MM\/PBSA and MM\/GBSA methods. 5. improved docking performance using high solute dielectric constant MM\/GBSA and MM\/PBSA rescoring. Phys Chem Chem Phys 2014,16(40),22035-22045","journal-title":"Phys Chem Chem Phys"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"22129","DOI":"10.1039\/C6CP03670H","volume":"18","author":"Chen F.","year":"2016","unstructured":"Chen F.; Liu H.; Sun H.; Pan P.; Li Y.; Li D.; Hou T.; Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 6. capa-bility to predict protein\u2013protein binding free energies and re-rank binding poses generated by protein\u2013protein docking. Phys Chem Chem Phys 2016,18(32),22129-22139","journal-title":"Phys Chem Chem Phys"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"8408","DOI":"10.1021\/jp404160y","volume":"117","author":"Xu L.","year":"2013","unstructured":"Xu L.; Sun H.; Li Y.; Wang J.; Hou T.; Assessing the performance of MM\/PBSA and MM\/GBSA methods. 3. the impact of force fields and ligand charge models. J Phys Chem B 2013,117(28),8408-8421","journal-title":"J Phys Chem B"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"51","author":"Hou T.","year":"2011","unstructured":"Hou T.; Wang J.; Li Y.; Wang W.; Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. the accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 2011,51(1),69-82","journal-title":"J Chem Inf Model"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/jcc.21666","volume":"32","author":"Hou T.","year":"2011","unstructured":"Hou T.; Wang J.; Li Y.; Wang W.; Assessing the performance of the molecular mechanics\/poisson boltzmann surface area and molecular mechanics\/generalized born surface area methods. ii. the accuracy of ranking poses generated from docking. J Comput Chem 2011,32(5),866-877","journal-title":"J Comput Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"Wang E.","year":"2019","unstructured":"Wang E.; Sun H.; Wang J.; Wang Z.; Liu H.; Zhang J.Z.H.; Hou T.; End-point binding free energy calculation with mm\/pbsa and mm\/gbsa: Strategies and applications in drug design. Chem Rev 2019,119(16),9478-9508","journal-title":"Chem Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"W322","DOI":"10.1093\/nar\/gkz397","volume":"47","author":"Weng G.","year":"2019","unstructured":"Weng G.; Wang E.; Wang Z.; Liu H.; Zhu F.; Li D.; Hou T.; HawkDock: A web server to predict and analyze the protein\u2013protein com-plex based on computational docking and MM\/GBSA. Nucleic Acids Res 2019,47(W1),W322-W330","journal-title":"Nucleic Acids Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"Onufriev A.","year":"2004","unstructured":"Onufriev A.; Bashford D.; Case D.A.; Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 2004,55(2),383-394","journal-title":"Proteins"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1021\/acs.molpharmaceut.7b00631","volume":"14","author":"Lei T.","year":"2017","unstructured":"Lei T.; Sun H.; Kang Y.; Zhu F.; Liu H.; Zhou W.; Wang Z.; Li D.; Li Y.; Hou T.; ADMET evaluation in drug discovery. 18. reliable prediction of chemical-induced urinary tract toxicity by boosting machine learning approaches. Mol Pharm 2017,14(11),3935-3953","journal-title":"Mol Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1021\/acs.jcim.9b00801","volume":"59","author":"Wu Z.","year":"2019","unstructured":"Wu Z.; Lei T.; Shen C.; Wang Z.; Cao D.; Hou T.; ADMET evaluation in drug discovery. 19. reliable prediction of human cytochrome P450 inhibition using artificial intelligence approaches. J Chem Inf Model 2019,59(11),4587-4601","journal-title":"J Chem Inf Model"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1021\/mp400450m","volume":"11","author":"Li D.","year":"2014","unstructured":"Li D.; Chen L.; Li Y.; Tian S.; Sun H.; Hou T.; ADMET evaluation in drug discovery. 13. development of in silico prediction models for P-glycoprotein substrates. Mol Pharm 2014,11(3),716-726","journal-title":"Mol Pharm"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1021\/mp100444g","volume":"8","author":"Tian S.","year":"2011","unstructured":"Tian S.; Li Y.; Wang J.; Zhang J.; Hou T.; ADME evaluation in drug discovery. 9. prediction of oral bioavailability in humans based on molecular properties and structural fingerprints. Mol Pharm 2011,8(3),841-851","journal-title":"Mol Pharm"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666221208143327","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211785\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666221208143327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T17:19:03Z","timestamp":1692551943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211785\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409919666221208143327","relation":{},"ISSN":["1573-4099"],"issn-type":[{"type":"print","value":"1573-4099"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}